Skip to main content

Movers & Shakers: Dec 3, 2010


Aushon Biosystems has appointed Sven Beushausen to be its new chief scientific officer. He joins the Billerica, Mass.-based protein array technologies firm from Pfizer, where he was molecular medicine site leader.

Beushausen also has held other senior scientific positions within Pfizer, and previously worked as director of manufacturing technologies for Invitrogen (now Life Technologies).

Caris Life Sciences announced last week several recent additions and appointments to its senior scientific staff at its facilities in Lausanne, Switzerland, and Phoenix, Ariz.

Andy Tasinato was named director of research at the company's new R&D lab in Lausanne. Previously he was head of research at the University Hospital Lausanne and Bern. He will be overseeing Elodie Ristorcelli, who received her doctorate in biochemistry at the Faculty of Medicine in Marseille; and Gherici Hassaine, previously head of BioXtal's R&D laboratory.

Dan Holterman joined the company's Phoenix facility as a senior research scientist along with scientists Wang-Juh Chen, Jorge Schettini, and Tassilo Hornung.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.